<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05025982</url>
  </required_header>
  <id_info>
    <org_study_id>combination</org_study_id>
    <nct_id>NCT05025982</nct_id>
  </id_info>
  <brief_title>Combination of Lymphatico-venular Anastomosis and Liposuction to Treat Cancer-related Lymphedema</brief_title>
  <official_title>Combination of Lymphatico-venular Anastomosis and Liposuction to Treat Cancer-related Lymphedema: Rationale for a Regional Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Siena</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Siena</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  cooperation of an International team with many years of experience in surgical&#xD;
           management of lymphedema&#xD;
&#xD;
        -  description of an effective surgical strategy to treat cancer-related lymphedema, a high&#xD;
           incidence pathology&#xD;
&#xD;
        -  the combination of LVA and liposuction guarantees long lasting results&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cancer-related lymphedema represents one of the major complications of cancer treatment,&#xD;
      especially for breast and gynecologic cancers. Moreover, it has high impact on cancer&#xD;
      survivors and healthcare systems. Lymphedema management still remains challenging. The better&#xD;
      understanding of lymphedema physiopathology as well as the development of sophisticated&#xD;
      surgical and diagnostic techniques have led to effective strategies to address lymphedema&#xD;
      patients but, despite the considerable interest in international literature, no consensus&#xD;
      exist. The combination of LVA and liposuction may represent an effective strategy in treating&#xD;
      patients with cancer-related lymphedema, in order to reach a significant decrease in volume&#xD;
      and reduction of lymphangitis rate as well as stable results in time. In addition, it has the&#xD;
      aim of being minimally invasive and well tolerated by patients&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Anticipated">May 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>change in volume</measure>
    <time_frame>one year</time_frame>
    <description>change in volume of the limb affected by cancer-related lymphedema</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Description of an Effective Surgical Strategy to Treat Cancer-related Lymphedema</condition>
  <condition>Combination of LVA and Liposuction Guarantees Long Lasting Results</condition>
  <arm_group>
    <arm_group_label>Group of partecipants</arm_group_label>
    <description>we combined two surgical techniques in the same group of patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>combination of lymphaticovenular anastomosis and liposuction</intervention_name>
    <description>Surgeries were carried out under local anesthesia and light sedation.LVA was performed adopting supramicrosurgical technique.Liposuction was performed following completion of the LVA</description>
    <arm_group_label>Group of partecipants</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with a previous history of cancer who developed secondary lymphedema and are&#xD;
        currently free from cancer&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: patients affected by secondary lymphedema&#xD;
&#xD;
          -  free from cancer disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - persistence of the neoplastic pathology&#xD;
&#xD;
        - patients affected by primary lymphedema&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Guido Gabriele, MD</last_name>
    <phone>3351355043</phone>
    <email>guidogabriele1@yahoo.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Guido Gabriele</name>
      <address>
        <city>Siena</city>
        <zip>54100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guido Gabriele, MD</last_name>
      <email>guidogabriele1@yahoo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Guido Gabriele</name>
      <address>
        <city>Siena</city>
        <zip>54100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guido Gabriele, MD</last_name>
    </contact>
    <contact_backup>
      <email>guidogabriele1@yahoo.it</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 28, 2021</study_first_submitted>
  <study_first_submitted_qc>August 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 30, 2021</study_first_posted>
  <last_update_submitted>August 26, 2021</last_update_submitted>
  <last_update_submitted_qc>August 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Siena</investigator_affiliation>
    <investigator_full_name>Guido Gabriele</investigator_full_name>
    <investigator_title>Professor Guido Gabriele</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphedema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

